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Available online 16 June 2016Studies fromWestern countries suggest that smokers tend to display greater abdominal obesity than non-smokers,
despite showing lowerweight.Whether this holds true in a leaner population requires clariﬁcation. Using indices of
abdominal obesity including visceral adipose tissue, we examined whether lifetime cigarette smoking is associated
with unfavorable fat distribution among Japanese men.
From 2006 to 2008, we conducted a cross-sectional investigation of a community-based sample of Japanesemen
at 40–64 years old, free of cardiovascular diseases and cancer. Areas of abdominal visceral adipose tissue (VAT)
and subcutaneous adipose tissue (SAT) were calculated using computed tomography. We divided participants
into four groups: never-smokers; and tertiles of pack-years of smoking among ever-smokers. Usingmultivariable
linear regression, we calculated adjustedmeans of obesity indices (VAT, SAT, VAT-SAT ratio [VSR], and waist-hip
ratio [WHR]) for each group, and mean differences between consecutive groups.
We analyzed 513 men (median age, 58.2 years; current smokers, 40.1%). Two-thirds showed body mass index
(BMI) b 25 kg/m2 (median, 23.5 kg/m2). Overall, greater lifetime smoking group was associated with greater
WHR and VSR. On average, one higher smoking group was associated with 0.005 higher WHR (95% CI, 0.001–
0.008; P = 0.005) and 0.041 greater VSR (95% CI, 0.009–0.073; P = 0.012) after adjustment for potential con-
founders, including BMI. In this sample of relatively lean Japanese men, greater lifetime smoking was associated
with a metabolically more adverse fat distribution. Although smoking is commonly associated with lower BMI,
minimizing the amount of lifetime smoking should be advocated.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Smoking
Abdominal obesity
Visceral adipose tissue1. Introduction
Smokers tend to be leaner than non-smokers, although the long-term
effects of smoking on weight remain unclear and can be variable
(Audrain-McGovern and Benowitz, 2011; Chiolero et al., 2008). Theth, Shiga University of Medical
shi).
pendix A.
. This is an open access article underidea that cigarette smoking is helpful in controlling body weight
has remained popular (Audrain-McGovern and Benowitz, 2011),
and the fear of gaining weight discourages smokers from quitting
(Chiolero et al., 2008). Importantly, many population-based studies
have suggested that cigarette smoking is associated with a greater
degree of abdominal obesity (Bamia et al., 2004; Barrett-Connor
and Khaw, 1989; Kim et al., 2012; Shimokata et al., 1989b), despite
the lower weight/body mass index (BMI) observed in smokers (Canoy
et al., 2005; Jee et al., 2002). In most of those studies, however, abdom-
inal obesity was assessed using anthropometric measures such as waistthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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associated with either visceral adipose tissue (VAT) or subcutaneous
adipose tissue (SAT), or both thus remains unclear. This question is
important, as VAT has been suggested to play a more important role
than SAT in the pathogenesis of cardiometabolic derangements such
as diabetes mellitus (DM) and atherosclerosis (Farb and Gokce, 2015;
Perrini et al., 2008). In addition, most relevant studies have been
conducted in the United States or Europe, where BMI is generally higher
than in other regions, including Japan. We therefore aimed to examine
cross-sectional associations between lifetime cigarette smoking andmea-
sures of abdominal obesity, including computed tomography (CT)-based
assessments of VAT and SAT, in a population-based sample of Japanese
men.
2. Methods
2.1. Subjects
This is a cross-sectional investigation of an observational population-
based study. The subjects were male participants in a population-based
cohort study conducted in Japan, the Shiga Epidemiological Study of
Subclinical Atherosclerosis (SESSA). SESSA is a study of subclinical athero-
sclerosis and its determinants on a sample of Japanese residents, and
details of the methods of enrollment have been reported previously
(Kadota et al., 2013). In brief, from 2006 to 2008, we randomly selected
and invited 2379 Japanese men aged 40 to 79 years who were residents
of Kusatsu City, Shiga, based on the Basic Residents' Register of the city.
The Register contains information on name, sex, birth date, and address
of residents (Sekikawa et al., 2007). A total of 1094men agreed to partic-
ipate (The participation rate was 46%) (Kadota et al., 2013). The city,
located in central Japan, has an industrial structure similar to the average
of Japan: approximately two thirds and one-third are tertiary (i.e. service
industries) and secondary (mining, manufacturing, construction indus-
tries) sectors, respectively, and the remaining few percent is primary
sector (agriculture, forestry and ﬁshery industry) according to the
Ministry of Health, Labour and Welfare. For the present study, we
limited our analyses a priori to those 40–64 years old who were
free of cardiovascular disease and cancer at baseline (519 men). We
chose the age cut-off of 64 years as an exclusion criterion to minimize
the potential for older age to confound the association between smoking
and obesity. Japanese men tend to start losing weight, as reﬂected by a
decline in BMI, at around60–69 years old (Yatsuya et al., 2011). According
to the National Health and Nutrition Surveys in Japan, the proportion of
current male smokers starts to decrease around the same age
range (60–69 years), and continues to drop progressively with age
(JAPAN HEALTH PROMOTION & FITNESS FOUNDATION, 2008). This
simultaneous decline in body weight and smoking rates, likely rooted in
both biological and socio-behavioral bases, may introduce further
complexities and confounding to the relationship between exposure
and outcome (Hu, 2008), which we therefore intended to avoid in our
analyses.
The present study was carried out in accordance with the Code of
Ethics of the World Medical Association (Declaration of Helsinki) and
approved by the institutional review board of Shiga University of
Medical Science (Nos. 17–19, 17–83).
2.2. Measurements
Data onmedical history, use ofmedications, smoking, alcohol intake,
and other lifestyle factors were collected from each participant using a
self-administered questionnaire. Trained technicians conﬁrmed the
completed questionnaire with participants.
We assessed the amount of lifetime cigarette smoking in staged
questions. First, participants were asked “Have you smoked in the past
30 days? (Yes/No)”. Those answering “Yes”were categorized as current
smokers, and queried the average number of cigarettes he smokes eachday, and further asked the following question: “At what age did you
start smoking cigarettes regularly? (Age)”. For those who answered
“No”, the second question was “Have you smoked in the past?” If the
answer was “No”, we categorized the individual as a never-smoker,
and if the answer was “Yes”, we categorized him as a former smoker
and asked for further information on the ages at which he started and
ceased regular smoking, and the average number of cigarettes smoked
each day during those periods. Based on the resulting information, we
calculated the lifetime amount of cigarette smoking in pack-years,
deﬁned as the number of cigarettes smoked each day divided by 20,
then multiplied by the number of years of smoking. Among the former
smokers we categorized, three individuals reported same age for both
initiation and cessation of smoking. We treated those individuals as
former smokers with estimated pack-years of smoking of zero. The
frequency of physical activity in leisure timewas asked and categorized
as “often”, “occasional”, or “rare to never.”
Body weight and height were measured while the participant was
wearing light clothing without shoes. Circumferences of the waist and
hip were measured twice at the levels of the umbilicus and maximal
protrusion of the hip, respectively, in the end-exhalation phase while
the participantwas standing upright. Themean of the twomeasurements
was used for analysis. Blood pressure was measured twice consecutively
in the right arm of the seated participant after sitting quietly for
5 min, using an automated sphygmomanometer (BP-8800; Colin
Medical Technology, Komaki, Japan). The mean of these two measure-
ments was used for analyses. Blood specimens were obtained early in
the clinic visit after a 12-hour fast, and used for laboratory testing includ-
ing lipids and glucose concentrations, and other detailed were reported
previously. Serum lipid concentrations were determined at a single labo-
ratory (Shiga Laboratory; MEDIC, Shiga, Japan) that had been certiﬁed for
standardized lipid measurements according to the protocols of the US
Centers forDisease Control andPrevention/Cholesterol ReferenceMethod
Laboratory Network. Concentrations of glycated hemoglobin (HbA1c)
were measured using a latex agglutination inhibition assay according to
the standardized method of the Japan Diabetes Society. DM was deﬁned
from a fasting serum glucose ≥126 mg/dL (≥6.99 mmol/L), HbA1c ≥6.1%
(as per the Japan Diabetes Society protocol during the examination
period; equivalent to ≥6.5% in the National Glycohemoglobin Standardi-
zation Program (Kashiwagi et al., 2012)), or current treatment for DM.
2.3. Abdominal adipose tissue areas
Areas of VAT and SAT were assessed using CT. Abdominal VAT was
deﬁned as the fat enclosed by the inner aspect of the abdominal wall.
Abdominal SAT was deﬁned as the fat outside the outer aspects of the
abdominal wall, but not including that fat located within the muscular
fascia. While participants were supine, serial CT images were obtained
using a protocol similar to one described previously (Kadowaki et al.,
2006). A single CT image of the L4–L5 vertebral space was selected to
estimate areas of VAT and SAT. Adipose tissuewas identiﬁed as showing
attenuation between−190 and−30 Hounsﬁeld units combined with
anatomical interpretation by a reader. Studies of human cadavers have
shown that the area measured by CT offers an accurate estimate of
abdominal VAT,(Rossner et al., 1990) and the same or similar ranges
of attenuation have been adopted to estimate VAT/SAT in population
studies (DeNino et al., 2001; Ding et al., 2008; Fox et al., 2007; Wheeler
et al., 2005). The inner and outer aspects of the abdominal walls were
manually tracked, and respective areaswere calculated using image anal-
ysis software (SliceOmatic; Tomovision, Montreal, Canada). Two types of
CT scannerwere used during the examination period: a GE-Imatron C150
Electron Beam Tomography system (EBCT; GE Medical Systems, South
San Francisco, CA; slice thickness, 6 mm) for participants examined
from May 2006 through to August 2007 and a 16-row multidetector
row CT system (MDCT, Aquilion-16™; Toshiba Medical Systems, Tochigi,
Japan; slice thickness, 7 mm) for participants examined thereafter. All CT
images were analyzed at Shiga University of Medical Science by a trained
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Overall ﬁndings were similar between the CT types, so combined results
are presented with adjustment for CT type in statistical models.2.4. Statistical analysis
Among the 519 eligiblemen, we limited our analyses to thosewith no
missing CT-based abdominal obesity indices (VAT, SAT) and pertinent
variables including pack-years of smoking, resulting in the inclusion of
513 men for analysis. We divided these participants into four groups
based on reported smoking habits and pack-years of smoking: never-
smokers and tertiles of pack-years among current and former smokers
combined. To assess linear trends in the demographics of participants
according to estimated lifetime smoking, we treated the smoking group
variable as ordinal (0 = never, 1 = ﬁrst tertile, 2 = second tertile, and
3 = third tertile), then calculated P-values using linear regressions for
continuous variables and theMantel-Haenszel chi-square test for categor-
ical variables. We sought age-adjusted Pearson's correlation coefﬁcients
among BMI and abdominal obesity indices (WC, WHR, VAT, SAT, and
VAT-SAT ratio [VSR]). For main analyses, we ﬁrst obtained adjusted
means of abdominal obesity indices for each smoking group under no
linear assumption between lifetime smoking and the indices. We then
tested linear trends and obtained estimates of average difference (and
95% conﬁdence intervals (95% CIs)) between consecutive smoking
groups using linear regression. Adjusting covariates were as follows:
Model 1, age (years) and CT-type (EBCT versusMDCT);Model 2, educa-
tion (years), treated DM (yes/no), frequency of physical activity in lei-
sure time (often, occasional, or rare-never), and drinking habit
(current, former, or never) in addition to Model 1; and Model 3, BMI
in addition toModel 2. TreatedDMwasdeﬁned as use of any antidiabet-
ic medications.
In subgroup analyses, we separately repeated regression analyses on
current smokers alone and former smokers alone using each group-
speciﬁc tertile of pack-years. In sensitivity analyses, we used DM (Yes/
No) to replace treated DM in regression models of the main analyses.
Because WHR was missing for 35 individuals (19 current smokers, 12
former smokers, and 4 never smokers), we conducted multiple imputa-
tions to consider this missing value with a set of 100 plausible substitutes
on the assumption of “missing at random” using theMarkov ChainMonte
Carlomethod, and presented the results of themain analyses. In sensitiv-
ity analyses, we examinedwhether themain results differed by the use of
complete data (n = 478) or multiple imputations (n = 513). Values of
P b 0.05 were considered signiﬁcant and all analyses were two-tailed.
SAS version 9.4 software (SAS Institute, Cary, NC) was used for all
statistical analyses.3. Results
For the 513 men studied, median age was 58.2 years, and 40.0%,
43.3%, and 16.7% of participants reported themselves as current, former,
and never-smokers, respectively. Two-thirds of study participants (350
of the 513) showed BMI b 25 kg/m2. Median [25th, 75th percentile]
values for lifetime smoking and BMI were 24 pack-years [5, 41 pack-
years], and 23.5 kg/m2 [21.5, 25.7 kg/m2], respectively. Demographics of
the participants according to estimated lifetime smoking are shown in
Table 1. Higher levels of smoking were associated with older age, lower
concentration of high-density lipoprotein cholesterol, higher concentra-
tion of triglycerides, and higher systolic blood pressure, but not with
higher BMI. Age-adjusted Pearson's correlation coefﬁcients (r) among
BMI and each index of abdominal obesity are shown in Table 2. BMI
was most strongly correlated with WC (r = 0.853), followed by SAT
(r = 0.818), VAT (r = 0.725) and WHR (r = 0.574). VSR showed a
moderate positive correlation with VAT (r = 0.439) and a moderate
negative correlation with SAT (r =−0.310).3.1. Main analyses
Unadjusted and adjusted means of abdominal obesity indices are
shown according to estimated lifetime smoking in Table 3. Throughout
the models, with or without adjustment for BMI, greater lifetime
smoking showed signiﬁcant, positive associations with higher WHR
and VSR. For example, adjusted means of WHR for never-, 1st, 2nd,
and 3rd tertiles of smokers were 0.908, 0.915, 0.918, and 0.924, with
mean differences per one group of 0.005 (95% CI: 0.001, 0.008; Ptrend =
0.005) after adjusting for age, CT type, years of education, treated DM,
physical activity in leisure time, drinking, and BMI (Model 3). Overall,
results of WC were similar to WHR.VAT tended to be greater in groups
with greater lifetime smoking, but no signiﬁcant difference was found
in any of the models. No clear pattern was seen between SAT and life-
time smoking.
3.2. Subgroup analyses
Tables 4 and 5 summarize the results of analyses restricted to current
smokers alone (n = 205) and former smokers alone (n = 222), respec-
tively. Among current smokers, we no longer observed signiﬁcant trends
in any of the obesity indices. ForWHR and VSR, however, the overall pos-
itive pattern was consistent with the main results. Results were similar
when indices were regressed according to the number of cigarettes
smoked per day (data not shown). Among former smokers, we observed
positive associations between greater lifetime smoking andnot onlyWHR
and VSR, but also VAT across the models. Sensitivity analysis replacing
DMwith treated DM (in Models 2 and 3) resulted in a slight attenuation
of the magnitude of relationships, as evidenced by the average difference
per onehigher category, but overall patterns remained similar to themain
results (Appendix B. Table A.1). Sensitivity analyses comparing estimates
of WHR from unimputed (complete data, N = 478) and from 100-times
imputed data (N = 513) showed similar results (Appendix B.
Tables A.2). Results were similar across the strata by education level
(highest education attained b16 years, vs ≥16 years, data not shown),
and we did not stratify by other socio-economic status due to lack of
other appropriate variables for stratiﬁcation.
4. Discussion
In this population-based, cross-sectional study of Japanese men,
higher amount of lifetime smoking was associated with greater indices
of abdominal obesity, namely WHR and VSR. The relationship between
smoking and obesity is complex and not yet completely understood. On
the one hand, numerous cross-sectional studies have indicated that
body weight and/or BMI are lower in smokers than in non-smokers
(Chiolero et al., 2008). On the other hand, however, many population-
based studies, conducted mostly in the United States (Barrett-Connor
and Khaw, 1989; Shimokata et al., 1989b) or Europe (Akbartabartoori
et al., 2005; Bamia et al., 2004; Canoy et al., 2005; Rosmond and
Bjorntorp, 1999; Seidell et al., 1991), have associated cigarette smoking
with a greater degree of abdominal obesity (assessed using either WHR
or WC)(Bamia et al., 2004; Barrett-Connor and Khaw, 1989; Kim et al.,
2012; Shimokata et al., 1989b) despite the lower BMI observed in
smokers (Canoy et al., 2005; Jee et al., 2002). The positive association
between pack-years of smoking and abdominal obesity identiﬁed in
our study is in line with these previous studies. Furthermore, our
study is one of only a few studies (Kim et al., 2012) to show differential
associations of smoking with two types of abdominal adipose tissue
assessed on CT: VAT and SAT. We observed a positive association of
lifetime smoking with an increased ratio of VAT to SAT. This ﬁnding is
intriguing because VAT and SAT correlated not only with each other
(r = 0.66) but also with BMI (r = 0.73, 0.82, respectively). Since VAT,
as compared to SAT, may be more strongly associated with adverse
cardiometabolic proﬁles such as inﬂammation, insulin resistance (Shah
et al., 2014), DM (Farb and Gokce, 2015; Perrini et al., 2008), and
Table 1
Demographics of men according to estimated pack-years of smoking (40–64 years, examined in 2006–2008, Shiga, Japan).
Never smoker Current and former smoker
T1 T2 T3
P
n 86
143 144 140
Pack-years (range) (0) (0−20) (21–39) (39–152)
Age, years 58.3 [48.1–62.3] 56.9 [46.5–61.4] 56.5 [49.3–61.4] 60.2 [56.3–62.5] b0.001
Education, years 14 [12–16] 12 [12–16] 12 [12–16] 12 [12–16] 0.025
Height, cm 168 [165–172] 170 [166–174] 169 [165–173] 168 [165–172] 0.462
Weight, kg 66.9 [61.5–72.9] 67.5 [61.8–72.9] 67.8 [59.9–74.9] 66.3 [60.0–74.4] 0.845
BMI, kg/m2 23.6 [21.7–25.4] 23.3 [21.5–25.4] 23.5 [21.2–26.1] 23.6 [21.6–25.7] 0.885
Total-c, mg/dL 206 [182–233] 212 [192–237] 208 [190–232] 208 [188–231] 0.786
HDL-c, mg/dL 61 [48–72] 59 [51–70] 58 [47–68] 50 [44–63] b0.001
TG, mg/dL 98 [67–145] 101 [72–150] 118 [76–178] 126 [84–189] b0.001
Glucose, mg/dL 95 [90–103] 97 [90–105] 96 [91–107] 99 [91–110] 0.100
HbA1c (NGSP*), % 5.7 [5.4–6.0] 5.7 [5.5–6.0] 5.7 [5.5–6.0] 5.8 [5.6–6.4] 0.001
Systolic BP, mmHg 129 [117–138] 128 [118–141] 130 [121–145] 133 [121–147] 0.019
DM, % 11.6 8.4 16.7 24.3 0.001
Treated DM, % 9.3 2.8 4.2 10.7 0.285
Hypertension, % 34.9 35.0 44.4 47.9 0.014
Smoking, % b0.001
Current 0.0 24.5 55.6 64.3
Former 0.0 75.5 44.4 35.7
Never 100.0 0.0 0.0 0.0
Drinking, % 0.838**
Current 74.4 84.6 84.7 77.9
Former 1.2 2.1 2.8 5.0
Never 24.4 13.3 12.5 17.1
Frequency of PA in leisure time, % 0.764
Often 18.6 18.9 23.6 17.1
Occasional 46.5 39.9 36.1 49.3
Rare to never 34.9 41.3 40.3 33.6
CT-type, EBCT, % 64.0 62.2 66.7 86.4 b0.001
1) Values for continuous variables are given as median [inter-quartile range]. 2) T1, T2, T3 denote ﬁrst, second and third tertiles of pack-years of cigarette smoking among current and
former smokers combined. 3) *HbA1c was measured in accordance with the protocol of the Japan Diabetes Society (JDS), then converted to the equivalent value for the National
Glycohemoglobin Standardization Program (NGSP) using the following formula: 1.02 × HbA1c (JDS) (%) + 0.25. 4) Treating the smoking category variable (never, T1–T3 for smokers)
as ordinal, P-valueswere sought using linear regressions for continuous variables, and theMantel-Haenszel chi-square test for categorical variables. ** P-valuewas obtained after collapsing
the drinking category to “current” vs “non-current” because former drinkers were too few to allow testing the Mantel-Haenszel chi-square test.
Abbreviations: BMI, body mass index; VAT, abdominal visceral adipose tissue; SAT, abdominal subcutaneous adipose tissue; VSR, VAT-SAT ratio; Total-c, total-cholesterol, HDL-c, high
density lipoprotein cholesterol; TG, triglycerides; BP, blood pressure; DM, diabetes mellitus; PA, physical activity; EBCT, electron-beam computed tomography.
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support for the idea that a greater amount of lifetime smoking is
linked to a metabolically more adverse fat distribution (Canoy et al.,
2005). The well-documented association between smoking and DM
(Pan et al., 2015;Willi et al., 2007) could be explained in part by visceral
fat accumulation (Chiolero et al., 2008), and our ﬁnding is consistent
with this hypothesis. Our study adds an important piece to the body
of scientiﬁc evidence against a popular belief that smoking is an efﬁcientTable 2
Age-adjusted Pearson's correlation coefﬁcients among obesity indices (n= 478).
BMI (kg/m2) WC (cm) WHR VAT (cm2) SAT (cm2)
WC 0.853 – – – –
WHR 0.574 0.797 – – –
VAT 0.725 0.794 0.641 – –
SAT 0.818 0.846 0.624 0.658 –
VSR −0.066*** 0.005** 0.095* 0.439 −0.310
Unless otherwise speciﬁed, all Ps b 0.0001.
Because 35 of the 513 participants had missing WHR, all coefﬁcients were obtained from
the remaining 478 participants.
Abbreviations. BMI, bodymass index;WC, waist circumference;WHR, waist-to-hip ratio;
VAT, area of abdominal visceral adipose tissue; SAT, area of abdominal subcutaneous
tissue.
⁎ P= 0.039.
⁎⁎ P= 0.911.
⁎⁎⁎ P= 0.149.way to control body weight (Potter et al., 2004) as we showed that
smoking was associated with (relative) increase in abdominal obesity
at a given body mass (Morris et al., 2015).
Importantly, our study sample seems to show one of the lowest
levels of BMI among the relevant studies. For example, Kim et al. reported
that greater WC and greater CT-measured abdominal VAT were
associated with higher life-time smoking in their hospital-based
cross-sectional study in Korea (Kim et al., 2012). BMI for their sample
(mean, 26.4 kg/m2; standard deviation, 4.8 kg/m2) was similar or closer
to those studies from the United States and Europe (Akbartabartoori
et al., 2005; Bamia et al., 2004; Canoy et al., 2005; Shimokata et al.,
1989a), and much higher than BMI for our study sample (mean,
23.7 kg/m2; standard deviation, 3.0 kg/m2). Our ﬁndings thus add
to the literature conﬁrming the association between smoking and
abdominal obesity even in leaner populations.
In subgroup analyses of current or former smokers alone, the positive
association between lifetime smoking and abdominal obesity was signif-
icant only in former smokers, not in current smokers. In current smokers,
however,most of ourmodels showed agraded increase in point estimates
of WHR and VSR across tertiles. Smoking has probable acute anorexic
effects and metabolic properties that favor weight control (Chiolero
et al., 2008), but also has other properties thatmay predispose to abdom-
inal obesity, such as insulin resistance related to the release of catechol-
amines (Benowitz, 2003) and cortisol (Chiolero et al., 2008). In fact,
other population-based studies have reported a positive association
between amount of smoking and abdominal obesity within current
smokers (Canoy et al., 2005; Clair et al., 2011; Kim et al., 2012). The
Table 3
Unadjusted and adjustedmeans of abdominal obesity indices according to estimated lifetime smoking among all participants (513men, aged 40–64 years, examined in 2006–2008, Shiga,
Japan).
Never smokers
Current and former smokers
Estimated mean difference
per 1 higher category (95% CI) Trend P
T1 T2 T3
N 86 143 144 140
Pack-years (range) (0) (0–20) (21–39) (39–152)
WC, cm Mean (unadjusted) 84.5 85.0 85.6 86.1 0.540 (−0.10, 1.18) 0.100
Model 1 84.6 85.0 85.6 86.6 0.687 (0.03, 1.34) 0.040
Model 2 85.9 86.3 87.1 87.6 0.590 (−0.06, 1.24) 0.076
Model 3 84.3 85.1 85.0 85.9 0.462 (0.11, 0.82) 0.010
WHRa Mean (unadjusted) 0.906 0.910 0.916 0.925 0.006 (0.002, 0.010) 0.002
Model 1 0.907 0.911 0.918 0.925 0.006 (0.002, 0.010) 0.004
Model 2 0.915 0.920 0.927 0.931 0.005 (0.001, 0.010) 0.010
Model 3 0.908 0.915 0.918 0.924 0.005 (0.001, 0.008) 0.005
VAT, cm2 Mean (unadjusted) 114 114 119 121 2.8 (−1.5, 7.2) 0.202
Model 1 114 114 119 124 3.8 (−0.7, 8.2) 0.094
Model 2 119 118 124 127 3.1 (−1.3, 7.6) 0.165
Model 3 109 111 112 117 2.5 (−0.6, 5.5) 0.118
SAT, cm2 Mean (unadjusted) 122 124 126 117 −1.7 (−6.1, 2.7) 0.449
Model 1 123 124 128 126 1.0 (−3.4, 5.4) 0.652
Model 2 136 137 141 136 0.2 (−4.2, 4.6) 0.925
Model 3 125 129 127 125 −0.6 (−3.1, 2.0) 0.669
VSR Mean (unadjusted) 0.960 0.961 1.013 1.112 0.055 (0.023, 0.086) 0.001
Model 1 0.945 0.951 0.996 1.060 0.041 (0.009, 0.073) 0.012
Model 2 0.879 0.875 0.923 0.990 0.041 (0.009, 0.073) 0.013
Model 3 0.885 0.879 0.930 0.996 0.041 (0.009, 0.073) 0.012
Adjusting covariates: Model 1: age (years), CT type; Model 2: education (years), treated DM (yes/no), frequency of physical activity in leisure time (often, occasional, rare-to-never), and
drinking habit (current, former, never) in addition to Model 1; Model 3: body mass index (kg/m2) in addition to Model 2. Abbreviations: T1, T2, and T3 denote ﬁrst, second, and third
tertiles of pack-years of smoking among current and former smokers combined. WC, waist circumference; WHR, waist-to-hip ratio; VAT, area of abdominal visceral adipose tissue
(cm2); SAT, area of abdominal subcutaneous adipose tissue (cm2); VSR, VAT-SAT ratio.
Trend Ps were calculated using an ordinal variable for the 4 groups (never, tertiles of smokers) in the linear regression models.
a Estimates for WHR were obtained using 100-times imputed plausible WHR values for the 35 participants with missing data for WHR.
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studies remain unclear. One speculative explanation is that the relation-
ship in current smokersmay be less strong as compared to that in formerTable 4
Unadjusted and adjusted means of each index of abdominal obesity according to estimated lif
2008, Shiga, Japan).
T1 T2
n 68 69
Pack-years (range) (1–29) (30–44) (44–113)
WC, cm Mean (unadjusted) 85.4 86.5
Model 1 84.7 86.7
Model 2 86.5 88.5
Model 3 85.5 85.9
WHRa Mean (unadjusted) 0.912 0.922
Model 1 0.913 0.923
Model 2 0.931 0.941
Model 3 0.927 0.931
VAT, cm2 Mean (unadjusted) 118 121
Model 1 115 125
Model 2 121 131
Model 3 115 115
SAT, cm2 Mean (unadjusted) 130 130
Model 1 120 132
Model 2 135 147
Model 3 128 129
VSR Mean (unadjusted) 0.939 1.041
Model 1 0.991 1.038
Model 2 0.904 0.953
Model 3 0.912 0.974
Adjusting covariates: Model 1: age (years), CT type; Model 2: education (years), treated DM (y
drinking habit (current, former, never) in addition to Model 1; Model 3: body mass index (kg
tertiles of pack-years of smoking among current smokers.WC,waist circumference;WHR,wais
subcutaneous adipose tissue (cm2); VSR, VAT-SAT ratio.
Trend Ps were calculated using an ordinal variable for the 4 groups (never, tertiles of smokers)
a Estimates for WHR were obtained using 100-times imputed plausible WHR values for thesmokers, given the acute anorexic effect of smoking (Jessen et al., 2005;
Perkins et al., 1991). A greater sample size and/or wider range of BMIs
may thus be required to demonstrate the relationship among currentetime smoking among current smokers (205 men, aged 40–64 years, examined in 2006–
T3
Estimated mean difference per 1
group higher category (95% CI) Trend P
68
85.9 0.27 (−1.09, 1.63) 0.698
86.4 0.81 (−0.68, 2.30) 0.285
87.9 0.66 (−0.84, 2.16) 0.386
86.5 0.47 (−0.33, 1.28) 0.248
0.924 0.006 (−0.002, 0.014) 0.161
0.925 0.006 (−0.003, 0.015) 0.196
0.941 0.005 (−0.005, 0.014) 0.330
0.935 0.004 (−0.004, 0.012) 0.337
113 −2.3 (−11.3, 6.7) 0.611
119 1.8 (−8.0, 11.6) 0.717
125 1.7 (−8.3, 11.6) 0.744
116 0.6 (−6.1, 7.3) 0.869
112 −9.2 (−19.0, 0.6) 0.066
118 −1.5 (−12.0, 9.0) 0.776
132 −1.9 (−12.5, 8.6) 0.718
122 −3.2 (−9.0, 2.5) 0.271
1.081 0.071 (0.008, 0.134) 0.028
1.058 0.033 (−0.035, 0.101) 0.341
0.976 0.036 (−0.033, 0.105) 0.309
0.988 0.037 (−0.031, 0.106) 0.285
es/no), frequency of physical activity in leisure time (often, occasional, rare-to-never), and
/m2) in addition to Model 2. Abbreviations: T1, T2, and T3 denote ﬁrst, second, and third
t-to-hip ratio; VAT, area of abdominal visceral adipose tissue (cm2); SAT, area of abdominal
in the linear regression models.
19 current smokers with missing data for WHR.
Table 5
Unadjusted and adjustedmeans of each index of abdominal obesity according to estimated lifetime smoking among former smokers (222men, aged40–64 years, examined in2006–2008,
Shiga, Japan).
T1 T2 T3
Estimated mean difference per 1
group higher category (95% CI) Trend P
n 74 75 73
Pack-years (range) (0−13) (14–32) (33–152)
WC, cm Mean (unadjusted) 84.8 84.0 86.9 1.06 (−0.21, 2.33) 0.102
Model 1 85.1 84.6 88.0 1.44 (0.16, 2.72) 0.028
Model 2 85.3 85.1 87.9 1.29 (−0.01, 2.59) 0.052
Model 3 84.2 83.9 84.9 0.29 (−0.38, 0.96) 0.399
WHRa Mean (unadjusted) 0.906 0.908 0.930 0.012 (0.004, 0.020) 0.004
Model 1 0.908 0.910 0.932 0.012 (0.004, 0.020) 0.003
Model 2 0.907 0.911 0.931 0.012 (0.004, 0.020) 0.005
Model 3 0.902 0.906 0.917 0.007 (0.001, 0.014) 0.029
VAT, cm2 Mean (unadjusted) 109 113 134 12.3 (3.5, 21.0) 0.006
Model 1 107 113 137 14.6 (5.7, 23.6) 0.002
Model 2 99 108 128 14.2 (5.3, 23.1) 0.002
Model 3 94 102 111 8.6 (2.2, 15.0) 0.009
SAT, cm2 Mean (unadjusted) 123 111 128 2.5 (−6.0, 11.1) 0.558
Model 1 128 119 143 7.4 (−0.8, 15.6) 0.078
Model 2 136 128 148 5.8 (−2.6, 14.2) 0.177
Model 3 130 121 130 0.0 (−5.4, 5.4) 0.991
VSR Mean (unadjusted) 0.922 1.059 1.124 0.101 (0.033, 0.169) 0.004
Model 1 0.867 0.996 1.040 0.087 (0.019, 0.155) 0.013
Model 2 0.712 0.871 0.908 0.100 (0.031, 0.168) 0.005
Model 3 0.711 0.871 0.907 0.100 (0.030, 0.169) 0.005
Adjusting covariates: Model 1: age (years), CT type; Model 2: education (years), treated DM (yes/no), frequency of physical activity in leisure time (often, occasional, rare-to-never), and
drinking habit (current, former, never) in addition to Model 1; Model 3: body mass index (kg/m2) in addition to Model 2. Abbreviations: T1, T2, and T3 denote ﬁrst, second, and third
tertiles of pack-years of smoking among former smokers.WC,waist circumference;WHR, waist-to-hip ratio; VAT, area of abdominal visceral adipose tissue (cm2); SAT, area of abdominal
subcutaneous adipose tissue (cm2); VSR, VAT-SAT ratio.
Trend Ps were calculated using an ordinal variable for the 4 groups (never, tertiles of smokers) in the linear regression models.
a Estimates for WHR were obtained using 100-times imputed plausible WHR values for the 12 former smokers with missing data for WHR.
230 A. Fujiyoshi et al. / Preventive Medicine Reports 4 (2016) 225–232smokers. The reason we observed a strong association in former smokers
may be related to post-cessation weight gains. An important ﬁnding of
our studywas that, among former smokers, VATwas signiﬁcantly greater
in those with higher lifetime smoking even after adjusting for BMI.
Former smokers with a greater amount of lifetime smoking, and thus
likely being more nicotine-dependent, are well documented to be at
risk of gaining more weight after tobacco cessation (Audrain-McGovern
and Benowitz, 2011; Chiolero et al., 2008),making themprone to abdom-
inal obesity (Xu et al., 2007).
4.1. Limitations and strengths
Because of the observational and cross-sectional nature of this study,
we were unable to prove the direction of causality of the observed
association between smoking and abdominal obesity. Likewise, we were
unable to refute the possibility of residual confounding, such as the one
by socio-economic status, despite our attempts to minimize such inﬂu-
ences, or the possibility that smoking merely offers a marker of a cluster-
ing of unhealthy lifestyle factors that favor abdominal obesity, such as
lower levels of physical activity and poor dietary habits.(Chiolero et al.,
2006) We conducted our study only on a relatively small sample size
(especially for non-smokers) of men aged 40–64 years from one city,
which may limit the applicability of our results to only men with similar
age and demographics to our sample. Furthermore, the possibility of
selection bias needs to be considered when generalizing our ﬁndings as
the participation rate of the study was 46%. Another limitation relates to
the fact that ourmethod of assessing smoking status andpack-years relies
primarily on self-report, thus, leading to potential misclassiﬁcation.
Although we attempted to minimize it by verifying the participant's
response by trained technicians with the participant, additional use of
biochemical veriﬁcation and/or information from participant's proxy
could yield more accurate classiﬁcation. Strengths of our study include
the population-based enrollment, use of a standardized protocol
in assessing outcomes, such as CT-based VAT and SAT, and other
adjusting covariates.5. Conclusions
We found that greater lifetime smoking was cross-sectionally associ-
ated with a greater degree of abdominal obesity in a relatively lean
population-based sample of Japanese men. Our ﬁndings, consistent with
previous studies, suggest that those with a greater amount of lifetime
smoking tend to showmetabolicallymore adverse fat distributions linked
to cardiometabolic diseases. Although smoking is commonly associated
with lower BMI, our ﬁndings and the other well-known health hazards
of smoking suggest that emphasis should be placed on avoiding the
initiation of smoking or, failing that, minimizing the amount of lifetime
smoking.
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